Bill Search

S 599
  • Introduced
    Jan 05, 2023
  • Passed Senate
    Jan 17, 2023
  • Passed Assembly
  • Signed into Law
S 599
New York Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Requires certain manufacturers of prescription drugs to notify the drug utilization review board of the proposed increase of the wholesale acquisition cost of such prescription drugs
Last Action See all actions
Senate • Jun 06, 2023: SUBSTITUTED BY A1707A
Latest Bill Text See all bill texts
S599A

Official Summary/Bill Text

Comments on S 599

Tweets

Whip Lists

Sponsors
Votes
Jan 17, 2023, Senate
Health Vote
YES: 12
NO: 3
OTHER: 0
YES: 12

NO: 3

OTHER: 0
Sources
Jan 17, 2023, Senate
Rules Vote
YES: 15
NO: 5
OTHER: 1
YES: 15

NO: 5

EXCUSED: 1

Sources
Jan 17, 2023, Senate
Floor Vote
YES: 48
NO: 14
OTHER: 1
YES: 48

NO: 14

EXCUSED: 1

Sources
Actions
  • Jun 06, 2023 | Senate
    • SUBSTITUTED BY A1707A
  • Jun 01, 2023 | Senate
    • VOTE RECONSIDERED - RESTORED TO THIRD READING
    • AMENDED ON THIRD READING 599A
  • May 31, 2023 | Assembly
    • RETURNED TO SENATE
  • May 31, 2023 | Senate
    • RECALLED FROM ASSEMBLY
  • May 30, 2023 | Assembly
    • SUBSTITUTION RECONSIDERED
    • RECOMMITTED TO HEALTH
  • May 15, 2023 | Assembly
    • SUBSTITUTED FOR A1707
    • ORDERED TO THIRD READING CAL.196
  • Jan 17, 2023 | Assembly
    • REFERRED TO HEALTH
  • Jan 17, 2023 | Senate
    • REPORTED AND COMMITTED TO RULES
    • ORDERED TO THIRD READING CAL.75
    • PASSED SENATE
    • DELIVERED TO ASSEMBLY
  • Jan 05, 2023 | Senate
    • REFERRED TO HEALTH
Bill Texts
Documents
Looks like we don't have any documents available at this moment.
Sources